Foghorn Therapeutics OverviewFoghorn Therapeutics Other Income Expense Net
Other Income/Expense Net for FHTX.
Quarterly Other Income/Expense
$1.70M
↓ 58.37% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$5.44M
↓ 62.63% YoY
Trailing 12 months ending Mar 31, 2026